Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination.
Batich, Kristen A
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research 04 2017 - 1898-1909 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article
1557-3265
10.1158/1078-0432.CCR-16-2057 doi
Adjuvants, Immunologic
Aged
Antineoplastic Agents--therapeutic use
Brain Neoplasms--immunology
Cancer Vaccines--therapeutic use
Combined Modality Therapy
Dacarbazine--administration & dosage
Dendritic Cells--immunology
Disease-Free Survival
Female
Glioblastoma--immunology
Granulocyte-Macrophage Colony-Stimulating Factor
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Phosphoproteins--immunology
T-Lymphocytes, Regulatory--immunology
Temozolomide
Viral Matrix Proteins--immunology
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research 04 2017 - 1898-1909 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article
1557-3265
10.1158/1078-0432.CCR-16-2057 doi
Adjuvants, Immunologic
Aged
Antineoplastic Agents--therapeutic use
Brain Neoplasms--immunology
Cancer Vaccines--therapeutic use
Combined Modality Therapy
Dacarbazine--administration & dosage
Dendritic Cells--immunology
Disease-Free Survival
Female
Glioblastoma--immunology
Granulocyte-Macrophage Colony-Stimulating Factor
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Phosphoproteins--immunology
T-Lymphocytes, Regulatory--immunology
Temozolomide
Viral Matrix Proteins--immunology